IND approval enables clinical trial advancement and enrollment of dose expansion cohorts in the US InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based
Adding deep preclinical and clinical immuno-oncology expertise to expand InteRNA's preclinical pipeline and accelerate clinical-stage lead candidate INT-1B3 InteRNA Technologies, a clinical-stage
InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment of Andrea van Elsas, PhD, as a new member
Further supporting the clinical validation of lead microRNA candidate INT-1B3 in solid tumors InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics
InteRNA Technologies Awarded € 2 7M Clinical Innovation Credit from Dutch Government yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.